Want to see IN:NUCLEUS full AI Analyst Report?
Nucleus Software Exports Limited (NUCLEUS) AI Stock Analysis
Nucleus Software Exports Limited
(NSE:NUCLEUS)
The overall score of 63 reflects a balance of strong structural fundamentals against weak technical momentum. The company's exceptional, near-zero leverage balance sheet and reasonable valuation (P/E of 17.39) act as primary strengths. However, the score is notably weighed down by bearish price trends across all key moving averages and recent margin compression that has negatively impacted profitability.
Nucleus Software Exports Limited (NUCLEUS) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 17.18B
- Dividend Yield
- 1.95%
- Average Volume (3M)
- 1,346
- Price to Earnings (P/E)
- 16.3
- Beta (1Y)
- 1.30
- Revenue Growth
- 1.66%
- EPS Growth
- -37.05%
- Country
- India
- Employees
- 1,954
- Sector
- General
- Sector Strength
- 55
- Industry
- Software - Application
Nucleus Software Exports Limited Business Overview & Revenue Model
Company Description
Nucleus Software Exports Limited, established in Noida, India, in 1986, is a prominent provider of essential software solutions for the financial services industry. The company delivers crucial lending and transaction banking products to clients span...
How the Company Makes Money
NUCLEUS primarily makes money by selling and supporting its banking software products to financial institutions. Key revenue streams typically include: (1) Software licensing or subscription fees for the use of its core platforms (often structured as...
Nucleus Software Exports Limited Financial Statement Overview
Summary
Nucleus Software Exports presents a mixed financial picture. The company boasts a pristine, virtually debt-free balance sheet. However, this is partially offset by margin compression and declining free cash flows despite steady top-line revenue growth.
Income Statement
52NeutralBalance Sheet
92Very PositiveCash Flow
68Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.69B | 8.76B | 8.32B | 8.26B | 6.34B | 4.97B |
| Gross Profit | 1.71B | 2.09B | 2.98B | 3.31B | 1.88B | 765.00M |
| EBITDA | 1.51B | 1.29B | 1.68B | 2.71B | 1.90B | 716.70M |
| Net Income | 1.05B | 1.17B | 1.63B | 1.92B | 1.28B | 409.10M |
Balance Sheet | ||||||
| Total Assets | 0 | 12.66B | 11.53B | 11.14B | 8.74B | 7.37B |
| Cash, Cash Equivalents and Short-Term Investments | 4.14B | 4.14B | 3.60B | 4.01B | 2.77B | 3.41B |
| Total Debt | 0 | 85.50M | 20.00M | 45.90M | 62.60M | 23.30M |
| Total Liabilities | -9.07B | 3.59B | 3.39B | 3.37B | 2.64B | 2.43B |
| Stockholders Equity | 9.07B | 9.07B | 8.14B | 7.77B | 6.11B | 4.94B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 915.70M | 1.36B | 1.93B | 461.40M | 334.30M |
| Operating Cash Flow | 0 | 1.20B | 1.51B | 2.22B | 498.40M | 576.70M |
| Investing Cash Flow | 0 | -551.10M | -207.80M | -1.97B | -127.00M | 1.59B |
| Financing Cash Flow | 0 | -365.00M | -1.26B | -301.60M | -226.50M | -2.13B |
Nucleus Software Exports Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:NUCLEUS, the sentiment is Negative. The current price of 623.80 is below the 20-day moving average (MA) of 652.07, below the 50-day MA of 686.41, and below the 200-day MA of 757.76, indicating a bearish trend. The MACD of -7.09 indicates Negative momentum. The RSI at 40.76 is Neutral, neither overbought nor oversold. The STOCH value of 39.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:NUCLEUS.
Nucleus Software Exports Limited Peers Comparison
Overall Rating
IN:NEWGEN82Outperform
IN:KFINTECH76Outperform
IN:EMUDHRA65Neutral
IN:NUCLEUS63Neutral
IN:INTELLECT60Neutral
IN:RAMCOSYS57Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 82Outperform | INR 63.05B | 19.58 | ― | 1.36% | 6.49% | -3.73% | |
| 76Outperform | INR 146.08B | 42.14 | ― | 1.42% | 26.83% | 0.50% | |
| 65Neutral | INR 28.25B | 24.11 | ― | 0.37% | 29.74% | 25.01% | |
| 63Neutral | INR 16.94B | 16.30 | ― | 1.95% | 1.66% | -37.05% | |
| 60Neutral | INR 70.88B | 19.90 | ― | 0.79% | 16.99% | -12.47% | |
| 57Neutral | INR 19.08B | 64.91 | ― | ― | 10.73% | 236.66% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:NUCLEUS | Nucleus Software Exports Limited | 643.45 | -375.81 | -36.87% | |
| IN:EMUDHRA | eMudhra Limited | 341.10 | -297.80 | -46.61% | |
| IN:INTELLECT | Intellect Design Arena Ltd | 504.60 | -683.25 | -57.52% | |
| IN:KFINTECH | Kfin Technologies Limited | 845.00 | -243.27 | -22.35% | |
| IN:NEWGEN | Newgen Software Technologies Limited | 442.45 | -541.23 | -55.02% | |
| IN:RAMCOSYS | Ramco Systems Limited | 507.10 | -115.65 | -18.57% |
Nucleus Software Exports Limited Corporate Events
Nucleus Software Grants 9,060 RSUs Under 2026 Equity Incentive Scheme
Nucleus Software Exports Limited has granted 9,060 restricted stock units under its Nucleus Software RSU Scheme 2026, each convertible into one equity share with a face value of Rs. 10. The grant, approved by the company’s Nomination and Remune...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 12, 2026